Necroptosis: a potential, promising target and switch in acute pancreatitis

被引:0
|
作者
Gang Wang
Feng-Zhi Qu
Le Li
Jia-Chen Lv
Bei Sun
机构
[1] The First Affiliated Hospital of Harbin Medical University,Department of Pancreatic and Biliary Surgery
来源
Apoptosis | 2016年 / 21卷
关键词
Acute pancreatitis; Necroptosis; Endoplasmic reticulum stress; Damage-associated molecular patterns; Inflammasome;
D O I
暂无
中图分类号
学科分类号
摘要
Pancreatic acinar cell death is the major pathophysiological change in early acute pancreatitis (AP), and the death modalities are important factors determining its progression and prognosis. During AP, acinar cells undergo two major modes of death, including necrosis and apoptosis. Acinar necrosis can lead to intensely local and systemic inflammatory responses, which both induce and aggravate the lesion. Necrosis has long been considered an unregulated, and passive cell death process. Since the effective interventions of necrosis are difficult to perform, its relevant studies have not received adequate attention. Necroptosis is a newly discovered cell death modality characterized by both necrosis and apoptosis, i.e., it is actively regulated by special genes, while has the typical morphological features of necrosis. Currently, necroptosis is gradually becoming an important topic in the fields of inflammatory diseases. The preliminary results from necroptosis in AP have confirmed the existence of acinar cell necroptosis, which may be a potential target for effectively regulating inflammatory injuries and improving its outcomes; however, the functional changes and mechanisms of necroptosis still require further investigation. This article reviewed the progress of necroptosis in AP to provide a reference for deeply understanding the pathogenic mechanisms of AP and identifying new therapeutic targets.
引用
收藏
页码:121 / 129
页数:8
相关论文
共 50 条
  • [21] ACLS4 could be a potential therapeutic target for severe acute pancreatitis
    Guo, Feng
    Lu, Yunkun
    Du, Lijun
    Guo, Xiuliu
    Xie, Jinyan
    Cai, Xiujun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [22] Inhibition of Necroptosis in Acute Pancreatitis: Screening for RIPK1 Inhibitors
    Yao, Jiaqi
    Luo, Yalan
    Liu, Xiaojun
    Wu, Ping
    Wang, Yin
    Liu, Yan
    Chen, Hailong
    Wen, Qingping
    PROCESSES, 2022, 10 (11)
  • [23] T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
    Zhou, Qi
    Tao, Xufeng
    Xia, Shilin
    Guo, Fangyue
    Pan, Chen
    Xiang, Hong
    Shang, Dong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [24] Necroptosis as a potential therapeutic target in multiple organ dysfunction syndrome
    Cui, Yao-Li
    Qiu, Li-Hua
    Zhou, Shi-Yong
    Li, Lan-Fang
    Qian, Zheng-Zi
    Liu, Xian-Ming
    Zhang, Hui-Lai
    Ren, Xiu-Bao
    Wang, Yong-Qiang
    ONCOTARGET, 2017, 8 (34) : 56980 - 56990
  • [25] Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target
    Chen, Jing
    Kos, Renate
    Garssen, Johan
    Redegeld, Frank
    CELLS, 2019, 8 (12)
  • [26] ACTIVIN IN ACUTE PANCREATITIS: POTENTIAL RISK-STRATIFYING MARKER AND NOVEL THERAPEUTIC TARGET
    Staudacher, Jonas J.
    Yazici, Cemal
    Carroll, Timothy
    Krett, Nancy
    Bauer, Jessica I.
    Xia, Yinglin
    Pang, Jingbo
    Wilson, Annette
    Papachristou, Georgios I.
    Whitcomb, David C.
    Fantuzzi, Giamila
    Jung, Barbara
    GASTROENTEROLOGY, 2017, 152 (05) : S894 - S894
  • [27] The potential of HBOC in acute pancreatitis
    Strate, T
    Mann, O
    Standl, T
    Izbicki, JR
    Knoefel, WT
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2001, 36 : S119 - +
  • [28] Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target
    Jonas J. Staudacher
    Cemal Yazici
    Timothy Carroll
    Jessica Bauer
    Jingbo Pang
    Nancy Krett
    Yinglin Xia
    Annette Wilson
    Georgios Papachristou
    Andrea Dirmeier
    Claudia Kunst
    David C. Whitcomb
    Giamila Fantuzzi
    Barbara Jung
    Scientific Reports, 7
  • [29] Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target
    Staudacher, Jonas J.
    Yazici, Cemal
    Carroll, Timothy
    Bauer, Jessica
    Pang, Jingbo
    Krett, Nancy
    Xia, Yinglin
    Wilson, Annette
    Papachristou, Georgios
    Dirmeier, Andrea
    Kunst, Claudia
    Whitcomb, David C.
    Fantuzzi, Giamila
    Jung, Barbara
    SCIENTIFIC REPORTS, 2017, 7
  • [30] Chymase as a Novel Therapeutic Target in Acute Pancreatitis
    Kuramoto, Toru
    Jin, Denan
    Komeda, Koji
    Taniguchi, Kohei
    Hirokawa, Fumitoshi
    Takai, Shinji
    Uchiyama, Kazuhisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)